We found that CELF2 expression exerted a positive effect on both OS and RFS in breast cancer and was significantly correlated with ER, PR, HER2 status, subtype, grade, lymph node status and TP53 status of patients (Table 1). This evidence concerns the gene TP53 and breast carcinoma.